retatrutide ada 2025 results 28.7% Weight Loss in New Study – Dr Brad Stanfield ADA 2026: Retatrutide Revolution

Wegovy is the only option of these three that has specifically been approved for use as a weight loss medication, only really differing from Ozempic by its recommended dosages

Compared with participants who received placebo injections, those treated with semaglutide showed: Slower biological aging across multiple epigenetic clocks tied to inflammation and the health of the blood, brain, heart, kidneys, liver, and metabolism

Traditional Weight-Loss Medications: How Do They Compare

GLP-1s are tools, not solutions

4 weeks 4 syringes 1 syringe per weekly injection

This distinction plays a crucial role in individualized care planning